I thought we were hearing for months, one of the unique strategies being employed with the rapid vaccine program was, millions (100?) of simultaneous with testing doses were in production, and waiting on the completion of the final phase 3 testing, meaning there would be effectively no ramp up, as the vaccine upon CDC? approval would be "needle ready". This was supposed to be a rather expensive, at taxpayer expense/risk in case approval was not forthcoming, and a never done before vaccine solution for the COVID 19 pandemic. Seems now, the initial doses will be slowly ramped up. What changed?